Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Pharmaceutical Product Lifecycle Management 2010-2020 |
Jul 2010 | £1,499 | 100% |
| Pharmaceutical Stability Testing Commercial Prospects 2011-2025 |
Nov 2010 | £1,499 | 99% |
| Commercial Insight: Antihypertensives New challenges for a maturing market |
Sep 2006 | £8,365 | 99% |
| Drug Delivery Technologies: Commercial Prospects 2010-2025 |
Oct 2010 | £1,499 | 98% |
| Comprehensive Analysis of R&D and Commercialization for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100 |
Feb 2007 | £945 | 98% |
| Commercial Insight: Osteoarthritis Market sees steady growth |
Dec 2006 | £8,365 | 97% |
| Technology Transfer Strategies A Guide to Maximizing Returns within The Pharmaceutical and Biopharmaceutical Industries |
May 2011 | £2,215 | 97% |
| Therapeutic Peptides in Oncology Favorable Conditions But Where to Commercialize? |
May 2009 | £2,940 | 97% |
| Antibiotic R&D Resolving the Paradox between Unmet Medical Need and Commercial Incentive |
Jul 2008 | £2,370 | 96% |
| Commercializing Peptides in Oncology A Decision Support Tool for Optimizing the Pipeline |
Jun 2010 | £2,035 | 96% |
| Psychopharmacotherapy Market Insights Obstacles & Opportunities in Mood Disorders & Cognitive Impairment, 2005-2012 |
Nov 2005 | £795 | 96% |
| Strategic Analysis of the Russian Pharmaceutical Market | Dec 2010 | £3,795 | 96% |
| Antithrombotic/Anticoagulant Drugs World Market Prospects 2010-2025 |
Sep 2010 | £1,499 | 96% |
| New Trends in Preventive and Therapeutic Vaccines - Overview R&D Activities and Commercial Prospects |
Oct 2011 | £1,580 | 96% |
| Commercializing Peptides in Cancer The Faster Route to Consider Your Options and Position of Others |
Nov 2011 | £2,035 | 95% |
| Chemotherapy Market Insights, 2006-2016 A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities |
Apr 2006 | £1,900 | 95% |
| Global Pharmaceutical Biotech Market 2010-2025 Market growth, novel technologies and expansion into new therapeutic areas |
Dec 2009 | £1,499 | 95% |
| Biosensor Market, R&D and Commercial Implication | Apr 2004 | £945 | 95% |
| Antibacterial Drugs Commercial Prospects 2011-2026 |
Jan 2011 | £1,499 | 95% |
| Commercializing Cancer Vaccines A Decision Support Tool for Optimizing the Pipeline |
Oct 2010 | £1,620 | 94% |
| Pharmaceutical Contract Manufacturing Industry and Market Prospects 2010-2025 |
Aug 2010 | £1,499 | 94% |
| Lexicon Pharmaceuticals Inc Premium Company Profile |
Apr 2008 | £315 | 94% |
| Pharmaceutical Anti-counterfeiting Technologies Market Analysis 2011-2021 |
Apr 2011 | £1,499 | 94% |
| Apoptotic Therapeutics in Oncology - Where to Commercialize? | Nov 2009 | £2,035 | 94% |
| Product Profiles: Multiple Sclerosis Gilenya raises bar for new market entrants |
Jun 2011 | £7,210 | 94% |
| Product Profiles: Depression Next generation vies for second-line patients |
Jun 2011 | £7,210 | 93% |
| Separation Systems for Commercial Biotechnology | Sep 2011 | £3,065 | 93% |
| Prospects for Pharma Mergers, Acquisitions and Alliances 2010-2020 |
Jul 2010 | £1,499 | 93% |
| Commercial Insight: Antihormonal Cancer Therapies | Jul 2009 | £9,615 | 93% |
| Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
Sep 2006 | £1,450 | 93% |
